Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

Similar articles for PubMed (Select 23459664)

1.

Postpartum depression: psychoneuroimmunological underpinnings and treatment.

Anderson G, Maes M.

Neuropsychiatr Dis Treat. 2013;9:277-87. doi: 10.2147/NDT.S25320. Epub 2013 Feb 21.

2.
3.
4.

Oxidative/nitrosative stress and immuno-inflammatory pathways in depression: treatment implications.

Anderson G, Maes M.

Curr Pharm Des. 2014;20(23):3812-47. Review.

PMID:
24180395
7.
8.

Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression.

Anderson G, Kubera M, Duda W, Lasoń W, Berk M, Maes M.

Pharmacol Rep. 2013;65(6):1647-54. Review.

9.

Treatment of postpartum depression: clinical, psychological and pharmacological options.

Fitelson E, Kim S, Baker AS, Leight K.

Int J Womens Health. 2010 Dec 30;3:1-14. doi: 10.2147/IJWH.S6938.

10.

Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites.

Anderson G, Maes M.

Curr Psychiatry Rep. 2015 Feb;17(2):8. doi: 10.1007/s11920-014-0541-1.

PMID:
25620790
11.

Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications.

Anderson G, Berk M, Dean O, Moylan S, Maes M.

CNS Drugs. 2014 Jan;28(1):1-10. doi: 10.1007/s40263-013-0119-1. Review.

PMID:
24150993
12.

A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers.

Lopresti AL, Maker GL, Hood SD, Drummond PD.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:102-11. doi: 10.1016/j.pnpbp.2013.09.017. Epub 2013 Oct 5. Review.

PMID:
24104186
13.

Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development?

Catena-Dell'Osso M, Bellantuono C, Consoli G, Baroni S, Rotella F, Marazziti D.

Curr Med Chem. 2011;18(2):245-55. Review.

PMID:
21110802
14.

Multiple sclerosis: The role of melatonin and N-acetylserotonin.

Anderson G, Rodriguez M.

Mult Scler Relat Disord. 2015 Mar;4(2):112-23. doi: 10.1016/j.msard.2014.12.001. Epub 2014 Dec 16.

PMID:
25787187
15.

The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression.

Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, Kubera M, Bob P, Lerer B, Maj M.

Metab Brain Dis. 2009 Mar;24(1):27-53. doi: 10.1007/s11011-008-9118-1. Epub 2008 Dec 16. Review.

PMID:
19085093
16.

Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala.

Anderson G, Maes M.

Curr Neuropharmacol. 2014 Mar;12(2):148-67. doi: 10.2174/1570159X11666131120223757.

17.

Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways.

Anderson G, Maes M, Berk M.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Apr 5;42:101-14. doi: 10.1016/j.pnpbp.2012.07.016. Epub 2012 Aug 22. Review.

PMID:
22930036
18.

Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.

Schefold JC, Zeden JP, Fotopoulou C, von Haehling S, Pschowski R, Hasper D, Volk HD, Schuett C, Reinke P.

Nephrol Dial Transplant. 2009 Jun;24(6):1901-8. doi: 10.1093/ndt/gfn739. Epub 2009 Jan 20.

19.

Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock.

Schefold JC, Zeden JP, Pschowski R, Hammoud B, Fotopoulou C, Hasper D, Fusch G, Von Haehling S, Volk HD, Meisel C, Schütt C, Reinke P.

Scand J Infect Dis. 2010 Mar;42(3):164-71. doi: 10.3109/00365540903405768.

PMID:
19958238
20.

A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness.

Maes M, Galecki P, Chang YS, Berk M.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):676-92. doi: 10.1016/j.pnpbp.2010.05.004. Epub 2010 May 12. Review.

PMID:
20471444
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk